|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
Verastem, the 15-Month Old Christoph Westphal Venture in Cancer Stem Cells, Seeks IPO
|
Luke Timmerman |
11/03/11 |
Boston
|
|
Biogen Eyes Cambridge Move, Vertex Licenses Alios Drugs, Concert Nabs GSK Payment, & More Boston-Area Life Sciences News
|
Erin Kutz |
06/24/11 |
Boston
|
|
Concert Pharmaceuticals Hits $4 Million Milestone in GSK Alliance
|
Arlene Weintraub |
06/20/11 |
Boston
|
|
Rich Aldrich, Biotech Powerbroker, Breaks Silence on New $87M Longwood Founders Fund
|
Ryan McBride |
01/06/11 |
Boston
|
|
How Eli Lilly Let a Billion-Dollar Molecule Slip Away and Make a Fortune for Vertex
|
Ryan McBride |
08/04/10 |
Boston
|
|
Adimab Inks Novartis Deal, GSK-Founded Tempero Pursues Hot Immunology Field, Metamark Gets $22M, & More Boston-Area Life Sciences News
|
Erin Kutz |
07/16/10 |
Boston
|
|
Concert Pharma Riding Potential $1B Glaxo Deal, Looks Ahead to Human Data on HIV Drug
|
Ryan McBride |
07/14/10 |
Boston
|
|
XSITE’s Biotech Gurus to Cover the State of New England Biotech, the Return of Platforms
|
Luke Timmerman |
06/07/10 |
Boston
|
|
The Vertex Alumni: Where Are They Now?
|
Luke Timmerman |
04/29/10 |
Boston
|
|
Sirtris Vet Michelle Dipp Takes Over Key Role at Glaxo as Westphal Returns to VC
|
Ryan McBride |
04/22/10 |
Boston
|
|
Christoph Westphal Resigns as Sirtris CEO, Takes Over Glaxo’s SR One Venture Arm
|
Ryan McBride |
04/21/10 |
Boston
|
|
Amplyx Pharmaceuticals, Led By Women, Builds Platform for Improving Drugs for HIV, Cancer
|
Luke Timmerman |
04/20/10 |
San Diego
|
|
Sirtris Founders Build New Venture Capital Fund, Keep Mum
|
Luke Timmerman |
02/12/10 |
Boston
|
|
Ironwood Nabs $75M in Deal With Japanese Firm, Gloucester Drug Gets FDA Approval, Alnylam Branches Into Biomanufacturing Tech, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
11/13/09 |
Boston
|
|
Concert Starts HIV Trial, Bags $12M From Glaxo to Help Challenge Gilead’s Once-Daily Pill
|
Luke Timmerman |
11/09/09 |
Boston
|
|
New England Venture Activity Rebounds Slightly in Q2—Region’s Top 10 Deals List
|
Ryan McBride |
07/21/09 |
Boston
|
|
E Ink Scooped up by Taiwanese Display Maker, EMC Battles NetApp For Data Domain, Polatis Picks Up $8M, & More Boston-Area Deals News
|
Rebecca Zacks |
06/05/09 |
Boston
|
|
GSK Cuts Deal with Concert to the Tune of a Potential $1B, Celldex Inks $94.5M CuraGen Acquisition, Aveo Touts Kidney Cancer Drug Data, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
06/03/09 |
Boston
|
|
Concert Pharma Jamming with Glaxo in Deal with $1B-Plus Potential
|
Ryan McBride |
06/02/09 |
Boston
|
|
Hey Life Sciences Fans, Remember The Deals Back in 2008…
|
Ryan McBride |
01/05/09 |
Boston
|
|
Biotech Veteran Talks of Hedge Fund Investing, Boston Celtics, and Hot Companies
|
Ryan McBride |
12/18/08 |
Boston
|
|
Biogen Idec Makes Controversial Tysabri Decision, Boston Scientific Explains Stock Sales, Charles River Heads to China, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
10/16/08 |
Boston
|
|
Concert Pharmaceuticals, Flush With Well-Timed Venture Round, Aims for Hot Flashes, HIV
|
Luke Timmerman |
10/14/08 |
Boston
|
|
Link Makes $40M Connection, Concert and Indevus Launch Clinicals, Genzyme’s Big Cholesterol Strategy, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
10/01/08 |
Boston
|
|
Concert Pharmaceuticals Enters Clinical Trials with Drug for Hot Flashes
|
Luke Timmerman |
09/25/08 |
Boston
|
|
Concert Strikes a Chord With Investors, Abiomed Scores a Win with Medicare, Epix Snags $7.5M from GSK, & More Life Sciences News
|
Rebecca Zacks |
05/07/08 |
Boston
|
|
Mascoma Teams with GM, Moldflow Melds with Autodesk, Concert Scores Some Heavy-Duty Cash, & More Deals News
|
Rebecca Zacks |
05/05/08 |
Boston
|
|
Concert Pharmaceuticals Garners $37,000,000 Series C Funding
|
VentureDeal |
04/30/08 |
Boston
|
|
Page 1 of
1 |
|
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.